Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Vandana G. Abramson
affiliation not provided to SSRN
Contact
affiliation not provided to SSRN
Email
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
42
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
A Composite 18f-Fdg Pet/Ct and Her2 Tissue-Based Biomarker to Predict Response to Neoadjuvant Pertuzumab and Trastuzumab in Her2-Positive Breast Cancer (Tbcrc026)
Number of pages: 33
Posted: 27 Nov 2024
Maeve Hennessy
,
Ashley Cimino-Mathews
,
Jodi M. Carter
,
Jennifer M. Kachergus
,
Yaohua Ma
,
Jeffrey P. Leal
,
Lilja B. Solnes
, Vandana G. Abramson,
Lisa A. Carey
,
Mothaffar F. Rimawi
,
Jennifer Specht
,
Ana Maria Storniolo
,
Christos Vaklavas
,
Ian Krop
,
Eric Winer
,
Rita Denbow
,
Vicente Valero
,
Antonio Wolff
,
Richard L. Wahl
,
Chiung-Yu Huang
,
Vered Stearns
,
E. Aubrey Thompson
and
Roisin M. Connolly
Cork University Hospital,
affiliation not provided to SSRN
, University of Alberta, Mayo Clinic, Mayo Clinic, Johns Hopkins University,
affiliation not provided to SSRN
,
affiliation not provided to SSRN
,
affiliation not provided to SSRN
, Baylor College of Medicine, University of Washington, Indiana University - School of Medicine,
affiliation not provided to SSRN
,
affiliation not provided to SSRN
,
affiliation not provided to SSRN
,
affiliation not provided to SSRN
, University of Texas at Houston - MD Anderson Cancer Center, Johns Hopkins University,
affiliation not provided to SSRN
,
affiliation not provided to SSRN
, Cornell University - Weill Cornell Medicine, Mayo Clinic and
affiliation not provided to SSRN
Downloads
42
(1,170,409)
View PDF
Download
Abstract:
18F-FDG PET/CT, HER2-Biomarkers, breast cancer, Neoadjuvant
Feedback